Cancer Institute NSW
Search this site  
Go
Cancer Institute NSW - home page Cancer Institute NSW - Info for Patients and Carers Cancer Institute NSW - Info for Health Professionals Cancer Institute NSW - Info for Researchers Standard Cancer Treatment Protocols

Print this page. Print this page

NSW Cancer Services Directory

Cancer Institute NSW Clinical Fellowship Program 2007

The Cancer Institute NSW Clinical Fellowship Program 2006 resulted in the appointment of 17 Clinical Fellows across NSW. After such a positive response to the program, the Cancer Institute NSW has coninued the program in 2007.

The Cancer Institute NSW Clinical Fellowship Program 2007 is designed to specifically address the need to provide a year of in-depth training and research for newly qualified specialists. The program aims to build upon and further support clinical cancer improvement, research and best practice.

In accordance with the Cancer Institute NSW Deed of Agreement, progress reports for 2007 Clinical Fellows must be submitted to the Cancer Institute NSW at the following intervals:

These reports enable to Cancer Institute NSW to assess whether satisfactory progress is being achieved. This report must be typed and submitted using this electronic form by the due date. A different reporting template will be provided for the final report at the conclusion of the fellowship program.

The Institute is proud to announce the appointment of eight Cancer Institute NSW Clinical Fellowships for 2007, commencing in January. The Cancer Institute NSW would like to congratulate all eight recipients, their supervisors and administering institutions.

1. Dr Colin Arnhold, Dr Richard Scolyer, Prof John Thompson, Prof Peter Hersey, Prof Richard Kefford and A/Prof Graham Mann (Supervisors)
Cancer Pathology, Royal Prince Alfred Hospital, SSWAHS
Research: Development of pathological and clinical pathways for "Treat, Resect, Analyse for Melanoma" ("TRAM") protocol.

2.



Dr David Chang, A/Prof Neil Merrett and Dr Andrew Biankin (Supervisors)
Upper Gastroinestinal and Pancreaticobiliary Surgical Oncology, Bankstown-Lidcombe Hospital, SSWAHS
Research: Patterns of care analysis for upper GI malignancy.

3.



Dr Annabel Goodwin, A/Professor Judy Kirk (Lead Supervisor)
Cancer Genetics, Westmead Hospital, SWAHS
Research: Validation of a questionnaire about the family history of bowel cancer.

4.



Dr Amanda Hugman, A/Professor Harry Iland, (Lead Supervisor)
Molecular Genetics of Haematological Malignancies/Haematology, Royal Prince Alfred Hospital, SSWAHS
Research: Investigating FLT3 as a prognostic determinant in acute promyelocytic leukaemia.

5.




Dr Samuel Kuo, Dr Thomas J Hugh, Dr Jas Samra and Professor Ross C Smith (Supervisors)
HeptoBiliary and Pancreatic Surgery, Royal North Shore Hospital, NSCCAHS
Research: Protein expression patterns in malignant gastrointestinal tumours: Comparison between Pancreatic Adenocarcinoma & colorectal liver metastases with clinical correlation and assessment of response to treatment.

6.



Dr Nam Nguyen, Dr Rupert Leong and A/Prof Neil Merrett (Supervisors)
Upper Gastroinestinal and Pancreaticobiliary Oncology Endoscopic Untrasound, Bankstown-Lidcombe Hospital, SSWAHS
Research: Improving the diagnostic accuracy of upper gastrointestinal and pancreaticobiliary tumours.

7. Dr Khimling Tew, Prof John Thompson, Dr Richard Scolyer, Prof Peter Hersey, Prof Richard Kefford and A/Prof Graham Mann (Supervisors)
Surgical Oncology, Royal Prince Alfred Hospital, SSWAHS
Research: Development of surgical and clinical pathways for "Treat, Resect, Analyse for Melanoma" ("TRAM") protocol.

8. Dr Rowena Martin, Dr Joseph Bucci (Lead Supervisor)
Radiation Oncology, St George Hospital, SESIAHS
Research: P rospective O utcomes-analysis for localised P rostate A denocarcinoma after R adiotherapy T reatment ( POP-ART )
This trial aims to determine the comparative urinary and anorectal functional outcomes for the patients treated with different techniques of radiotherapy (external beam radiotherapy, High-Dose-Rate brachytherapy with external beam radiotherapy, or Low-Dose-Rate brachytherapy). The outcome measures are detected by using both patient and physician-based symptom grading and urodynamic and anorectal physiology tests.

NSW Government | jobs.nsw

Accessibility | Terms of Use | Copyright & Disclaimer | Feedback | Privacy Statement | Site Map
© Copyright Cancer Institute NSW 2004-2008